WELL

HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF – Acc

Companies at the crossroads of medicine and technology that are shaping the future of healthcare.

Case for our Healthcare Megatrend ETF

Broad exposure to healthcare innovators

Healthcare innovations are well positioned to deliver strong growth rates given significant change and modernisation in the wake of COVID-19 and the availability of new technologies.

Capturing growth more efficiently through equal weighting

The Healthcare Megatrend ETF avoids concentration in larger stocks by using equal weighting, enabling smaller innovative companies to better contribute to performance. The number of companies in each sector is capped, avoiding overreliance.

ESG screen

WELL only includes companies that comply with the UN Global Compact principles, who are not involved with controversial weapons and who have low fossil fuel exposure.

As of 17.04.2024

Fund Objective

HAN-GINS Indxx Healthcare Megatrend Equal Weight UCITS ETF (WELL) is designed to capture securities at the cross-roads of medicine and technology which are shaping the future of healthcare. In a single trade, the Healthcare Megatrend ETF delivers equal weight exposure to over 100 global companies from the following 10 sub-themes: robotics; nanotechnology; genome sequencing; healthcare trackers; biological engineering; bioinformatics; neuroscience; medical devices; telemedicine and healthcare analytics.

Key Information

Inception Date04/04/2019
Base currencyUSD
Net Assets of Fund$15,930,216
TER59 bps
Replication MethodPhysical
DomicileIreland
SFDR ClassificationArticle 8
ISINIE00BJQTJ848

Key Risks

The value of equities and equity-related securities can be affected by daily stock and currency market movements. Emerging frontier markets are subject to greater market volatility than developed markets. Investors’ capital is fully at risk and investors may not get back the amount originally invested.

Fund Information

TickerWELL
Asset ClassEquities
Income TreatmentAccumulating
Rebalance FrequencySemi-Annually

Net Asset Values

NAV$6.54
Net Assets of Fund$15,930,216
Shares Outstanding2,435,809
Issuer AUM$1,113,697,464

Fund Structure

UCITS CompliantYes
UCITS EligibleYes
ISA EligibleYes
SIPP EligibleYes
UK Fund Reporting StatusYes
Sec LendingYes

Key service providers

CustodianJ.P. Morgan SE - Dublin Branch
Portfolio ManagerVident Advisory, LLC
IssuerHANetf ICAV

Registrations

Austria
Denmark
Finland
France
Germany
Ireland
Italy
Luxembourg
Mexico
Netherlands
Norway
Sweden
Switzerland
United Kingdom

Listings & Codes

ExchangeTickerRICSEDOLCCYListing Date
LSEWELL LNHAWELL.LBJVBGL7$2019-04-08
LSEWELP LNWELP.LBJVBGM8£2019-04-08
XetraW311 GYW311.DEBJ023542019-05-02
Borsa ItalianaWELL IMWELL.MIBHRWXD12019-04-19
SIXWELL SEWELL.SBMYC3R32020-06-02
BMVWELL1N MF-BMZQGH5MX$2022-03-15
Euronext ParisWELL FPWELP.PABPG9MZ42021-12-09
Exchange LSE
Ticker WELL LN
RIC HAWELL.L
SEDOL BJVBGL7
CCY $
Listing Date 2019-04-08
Exchange LSE
Ticker WELP LN
RIC WELP.L
SEDOL BJVBGM8
CCY £
Listing Date 2019-04-08
Exchange Xetra
Ticker W311 GY
RIC W311.DE
SEDOL BJ02354
CCY
Listing Date 2019-05-02
Exchange Borsa Italiana
Ticker WELL IM
RIC WELL.MI
SEDOL BHRWXD1
CCY
Listing Date 2019-04-19
Exchange SIX
Ticker WELL SE
RIC WELL.S
SEDOL BMYC3R3
CCY
Listing Date 2020-06-02
Exchange BMV
Ticker WELL1N MF
RIC -
SEDOL BMZQGH5
CCY MX$
Listing Date 2022-03-15
Exchange Euronext Paris
Ticker WELL FP
RIC WELP.PA
SEDOL BPG9MZ4
CCY
Listing Date 2021-12-09

Returns

WELL (Fund)IHMEQNT (Index)
1M-0.41%0.77%
3M-1.56%0.77%
6M9.55%0.77%
YTD-1.56%0.77%
12M-2.08%0.77%
3Y-33.59%-33.48%
Since Inception (04/04/2019)-7.17%-5.71%

Performance chart

NAV

Source: HANetf, data as of 31.03.2024. Please note that all performance figures are showing net data. Performance before inception is based on back-tested data. Back-testing is the process of evaluating an investment strategy by applying it to historical data to simulate what the performance of such a strategy would have been. Back-tested data does not represent actual performance and should not be interpreted as an indication of actual or future performance. Past performance for the index is in USD. Past performance is not an indicator for future results and should not be the sole factor of consideration when selecting a product. Investors should read the prospectus of the Issuer (“Prospectus”) before investing and should refer to the section of the Prospectus entitled “Risk Factors” for further details of risks associated with an investment in this product. If fund is less than 12 months old, YTD field will be calculated since inception. When you invest in ETFs your capital is at risk.

Holdings As of 17.04.2024

No. of holdings: 100

NameWeight
SHOCKWAVE MEDICAL INC1.89%
NATERA INC COMMON STOCK1.65%
HIMS & HERS HEALTH INC1.59%
SAREPTA THERAPEUTICS INC1.43%
4D MOLECULAR THERAPEUTICS1.37%
BOSTON SCIENTIFIC CORP1.35%
PROCEPT BIOROBOTICS CORP1.34%
TELIX PHARMACEUTICALS LTD1.34%
EDWARDS LIFESCIENCES CORP1.28%
DOCMORRIS AG COMMON STOCK1.28%

SectorWeight
Medical Devices31.95%
Biological Engineering27.97%
Genome Sequencing12.16%
Neuroscience9.56%
Telemedicine5.26%
Healthcare Analytics4.51%
Bioinformatics4.16%
Robotics3.25%
Healthcare Trackers1.15%
Other0.02%

Methodology

Companies are selected based on ten subthemes shaping the future of healthcare and are equally weighted. Rebalanced semi-annually.

Index Details

IndexIndxx Global NextGen Healthcare Index
Index CurrencyUSD
Index ProviderINDXX
Index TickerIHMEQNT
Index Dividend Yield
(As of 31.03.2024)
0.36%

Knowledge hub

Explore our expert-written monthly fund reports, periodic reviews, and key insights.

About Partner